BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%- betamethasone dipropionate 0.05% / niacinamide 4% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%

Directions for use. As directed by Physician. Apply topically. For external use only. Wash hands after use. Store at controlled room temperature 20-25 Celsius.

fs

Sincerus Florida, LLC. Adverse reactions

df

Active, inactive

wr

NDC 72934- 2026-2 BETAMETHASONE DIPROPIONATE USP 0.05% / NIACINAMIDE USP 4% Cream 30 gm.

sf

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4% 
betamethasone dipropionate 0.05% / niacinamide 4% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2026
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BETAMETHASONE DIPROPIONATE (UNII: 826Y60901U) (BETAMETHASONE - UNII:9842X06Q6M) BETAMETHASONE0.05 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2026-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/20/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/20/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2026)

Revised: 5/2019
Document Id: 89569a9d-d53e-f72d-e053-2a95a90aa9b9
Set id: 89569a9d-d53d-f72d-e053-2a95a90aa9b9
Version: 1
Effective Time: 20190520
 
Sincerus Florida, LLC